Orchid

Orchid is a biotechnology company based in San Francisco that specializes in reproductive genetics.

The company focuses on whole-genome embryo screening for in vitro fertilization (IVF) and preconception genetic risk assessment. Orchid's services are designed to assist intended parents and fertility clinics in identifying genetic risks before pregnancy, promoting healthier family-planning decisions. The core offerings include embryo screening reports and couple reports. Their embryo testing incorporates PGT-A, PGT-M, and comprehensive whole-genome screening to evaluate genetic risks for various severe monogenic conditions and inherited disease predispositions. Orchid aims to help families reduce the likelihood of passing on hereditary conditions through its advanced genetic screening services. The company serves patients and fertility clinics involved in the IVF process, providing genetic counseling support as part of its offerings.